Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLAS trial of amisulpride for very late-onset schizophrenia-like psychosis
2010-022184-35Phase 4Completed
- Sponsor
- King's College London
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia and Schizophrenia Spectrum Disorders (SSD) comparing Amisulpride with Placebo (2 arms). Primary endpoints: Brief Psychiatric Rating Scale improvement and Withdrawal due to perceived ineffectiveness. Started Sep 2011; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophreniaSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on 2010-022184-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022184-35.